Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products

Recent studies have demonstrated that the plasma soluble receptor for advanced glycation end-products (sRAGE) play a major role in developing macrovascular complications of type 2 diabetes, including peripheral arterial occlusion disease (PAOD). Cilostazol is an antiplatelet, antithrombotic agent, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrine
Main Authors: Liu, Jhih-Syuan, Chuang, Tsung-Ju, Chen, Jui-Hung, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Lin, Tsung-Kun, Hsiao, Fone-Ching, Hung, Yi-Jen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512567/
https://ncbi.nlm.nih.gov/pubmed/25666934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-015-0545-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados